Skip to content

A prospective safety study of laparoscopic total gastrectomy for clinical stageII or III gastric cancer

A prospective safety study of laparoscopic total gastrectomy for clinical stageII or III gastric cancer - A prospective study of laparoscopic total gastrectomy for advanced gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017724
Enrollment
135
Registered
2016-01-01
Start date
2016-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Sponsors

Nagoya University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Histologically proven gastric adenocarcinoma. (2) Clinical stage II or III according to the 14th edition of Japanese Classification of Gastric Carcinoma. (3) Aged over 20. (4) PS (ECOG) of 0 or 1. (5) No history of upper abdominal surgery and no history of intestinal resection except for appendectomy. (6) No prior treatment of chemotherapy or radiation therapy against any other malignancies. History of adjuvant hormone therapy after more than 1 year from the last administration is eligible. (7) Written informed consent.

Exclusion criteria

Exclusion criteria: (1) Synchronous or metachronous malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy. (2) concurrent resection of other organ. (3) Body mass index less than 30. (4) Infectious disease with systemic therapy indicated. (5) Body temperature of 38 or more degrees Celsius. (6) Pregnancy, possible pregnancy, within 28 days after delivery or breast-feeding. (7) Severe psychiatric disease. (8) Unstable angina pectoris, or history of myocardial infarction within six months. (9) Poorly controlled hypertension. (10) Poorly controlled diabetes mellitus in spite of continuous use of insulin. (11) Severe respiratory disease requiring continuous oxygen therapy.

Design outcomes

Primary

MeasureTime frame
postoperative complication rate

Countries

Japan

Contacts

Public ContactChie Tanaka

Nagoya University Graduate School of Medicine Department of Gastroenterological Surgery

chtanaka@med.nagoya-u.ac.jp052-744-2249

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026